Access Pharmaceuticals, Inc.
Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO
Published in Pharma Investments, Ventures and Law Weekly, January 13th, 2008
"I believe that Access has an exciting future with ProLindac(TM), MuGard(TM), and the Cobalamin Vitamin B-12 oral delivery technology. The Company is positioned well for 2008 to be an eventful year. Access has been a rewarding experience and I am proud of what has been achieved during the past year," noted Mr. Seiler.
The Board of Directors has appointed...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- 012 Smile.Communications Ltd
012 Smile.Communications to Deploy Extensive WiFi Internet Access System for Sheba Medical Center - 90octane
90octane Selected as Interactive Marketing Agency for Symetix Lead Generation Program - AARP
AARP Calls New EEOC Policy 'A Civil Rights and Economic Fiasco' - Abscess Therapy
Researchers at Women's and Children's Hospital have published new data on abscess therapy - Acid Reflux Disease
Reports from University of Louvain add new data to research in acid reflux disease - Acid Reflux Disease
Scientists at Technical University of Munich discuss research in acid reflux disease - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
